GlassScriptPhysician profile
Jie Kong
NPI 1215040951
$5,577.48
in general payments reported to CMS, 2019-2025
29 companies · $1,330 in 2025
The $1,330 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $452 · 2022: $799 · 2023: $1,024 · 2024: $1,972 · 2025: $1,330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,958 · Travel and Lodging: $289 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,957.60 |
| Travel and Lodging | $288.72 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $724.06 | 2022-2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $698.42 | 2021-2025 | |
| Pfizer INC. | $437.79 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $428.56 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $299.74 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $291.73 | 2021-2025 | |
| Philips North America LLC | $271.87 | 2023-2025 | (Ck4) Mcot, Ecc Solutions, Mcot |
| Astrazeneca Pharmaceuticals LP | $256.79 | 2021-2025 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $235.16 | 2022-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $233.58 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| Novo Nordisk INC | $226.82 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $214.27 | 2022-2025 | Amvuttra |
| Baxter Healthcare | $150.50 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.24 | 2022-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $130.38 | 2024 | Arcalyst |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $124.70 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.61 | 2022-2023 | Jardiance |
| Amgen INC. | $114.93 | 2021-2024 | Repatha |
| Ars Pharmaceuticals Operations, INC. | $100.00 | 2025 | Neffy |
| Amarin Pharma, INC. | $86.24 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $76.45 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $45.94 | 2024 | Zio Xt Patch, Zio Monitor |
| Bardy Diagnostics, INC. | $36.97 | 2022 | |
| Mannkind Corporation | $29.00 | 2025 | |
| Inspire Medical Systems, INC. | $25.11 | 2025 | Inspire |
| Kestra Medical Technology Services, INC. | $20.44 | 2024 | Assure Wcd |
| Medicomp INC | $18.79 | 2025 | Telepatch Cardiac Monitor |
| Cvrx, INC. | $17.94 | 2025 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $14.45 | 2024 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jie Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.